Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer

BACKGROUND: High serum phosphate and fibroblast growth factor-23 (FGF-23) levels are well-recognized independent risk factors of mortality and morbidity in patients with chronic kidney diseases (CKDs). Sevelamer, as a phosphate chelating agent, reduces serum phosphate and FGF-23 levels produced by b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghorbanihaghjo, Amir, Argani, Hassan, Golmohamadi, Zahra, Rashtchizadeh, Nadereh, Abbasi, Mehran Mesgari, Bargahi, Nasrin, Vatankhah, Amir Mansour, Sanajou, Davoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135647/
https://www.ncbi.nlm.nih.gov/pubmed/30237994
http://dx.doi.org/10.11005/jbm.2018.25.3.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135647/
https://www.ncbi.nlm.nih.gov/pubmed/30237994
http://dx.doi.org/10.11005/jbm.2018.25.3.153

Ejemplares similares